Company Cempra Inc Nasdaq
Equities
US15130J1097
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 48 | 03/20/03 | |
Susan Blum
DFI | Director of Finance/CFO | 52 | 01/16/01 |
Compliance Officer | 45 | - | |
Jisoo Park
PRN | Corporate Officer/Principal | - | 06/21/06 |
Kristen Allgor
HRO | Human Resources Officer | - | 16/20/16 |
John Harlow
PRN | Corporate Officer/Principal | - | 30/21/30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jonathan Leff
BRD | Director/Board Member | 55 | 20/20/20 |
Director/Board Member | - | 20/20/20 | |
Director/Board Member | - | 20/20/20 | |
Compliance Officer | 45 | - | |
Chief Executive Officer | 48 | 03/20/03 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 13,750,691 | 13,578,334 ( 98.75 %) | 0 | 98.75 % |
Company contact information
Melinta Therapeutics, Inc.
389 Interpace Parkway Suite 450
07054, Parsippany
+908-617-1300
http://melinta.comSector
1st Jan change | Capi. | |
---|---|---|
+16.45% | 12TCr | |
+21.96% | 12TCr | |
+23.73% | 2.7TCr | |
-20.05% | 2.04TCr | |
-16.28% | 1.59TCr | |
-16.52% | 1.64TCr | |
-44.35% | 1.56TCr | |
+63.91% | 1.49TCr | |
+2.52% | 1.36TCr |